Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Chemocentryx Inc (CCXI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2021	12-2020	09-2020	06-2020	03-2020
Assets
Current Assets
Cash & Cash Equivalents	68,548	32,297	56,177	333,205	59,436
Marketable Securities	307,736	404,273	415,207	171,415	124,255
Receivables	10,142	169	102	228	168
TOTAL	$390,641	$441,570	$474,442	$507,233	$186,669

Non-Current Assets
PPE Net	33,117	25,160	15,063	5,569	2,746
Investments And Advances	47,875	23,800	14,456	0	5,140
Other Non-Current Assets	27,479	28,369	29,081	29,242	2,747
TOTAL	$108,471	$77,329	$58,600	$34,811	$10,633

Total Assets	$499,112	$518,899	$533,042	$542,044	$197,302

Liabilities
Current Liabilities
Short Term Debt	9,609	6,302	3,066	N/A	N/A
Accounts payable and accrued liabilities	10,926	12,875	8,868	3,409	2,371
Accrued Expenses	21,156	19,794	18,938	19,279	14,811
Other current liabilities	N/A	N/A	6,173	6,173	N/A
TOTAL	$54,730	$51,558	$46,862	$56,365	$57,946

Non-Current Liabilities
Long Term Debt	14,866	18,099	21,260	51,698	24,178
Deferred Revenues	13,039	12,587	9,817	27,504	40,764
Other Non-Current Liabilities	45,175	39,629	35,287	746	783
TOTAL	$83,378	$81,728	$81,361	$64,538	$79,195

Total Liabilities	$138,108	$133,286	$128,223	$120,903	$137,141

Shareholders' Equity
Shares Outstanding, K	69,750	69,613	69,208	68,893	61,854
Common Shares	70	69	69	69	62
Retained earnings	-515,053	-485,342	-455,466	-431,406	-451,673
Other shareholders' equity	-30	98	256	472	201
TOTAL	$361,004	$385,613	$404,819	$421,141	$60,161

Total Liabilities And Equity	$499,112	$518,899	$533,042	$542,044	$197,302